Lithocholic acid 1 is an important metabolite of cholesterol in man and other animals. Interest in its biological properties stems from its marked toxicity. It is the most potent of the naturally occurring steroids that produce intense fever and inflammation in man (2, 3) and inflammation in a number of other species (3, 4) . It is also one of the most active steroid hemolysins (5) . In addition, its oral administration produces cirrhosis of the liver in rabbits (6) and ductular cell hyperplasia in a variety of species, including rodents (7), reptiles (8) , and primates (9) . In view of its physiological occurrence, its known toxic properties, and its potential relevance to human disease, we have investigated the effects of feeding large amounts of lithocholic acid to rats. The resulting bile duct hyperplasia and choledocholithiasis are described in this report.
Methods
The acute effects of lithocholic acid and sodium lithocholate on Sprague-Dawley rats were investigated in cially 2; no quantitatively significant bile acid contaminants were observed when it was analyzed by thin layer chromatography [system S15 of Eneroth (10) ]. The sodium salt was prepared by neutralization of the acid with sodium hydroxide.
In the first experiment, 5 male rats, average weight 372 g, were force fed 300 mg sodium lithocholate per kg body weight per day in a liquid diet (11) containing 3.6 g casein hydrolysate per kg body weight per day. The rats were fed 3 times daily at 8-hour intervals and killed with ether on the sixth day.
In the second experiment, 9 males and 9 females, average weight 171 g, were divided into 3 equal groups and force fed the basic liquid diet as described above. One group served as controls. A second group was fed lithocholic acid, 300 mg per kg body weight per day, in the diet. The third group received sodium lithocholate, 300 mg per kg body weight per day, in the diet All rats were killed with ether on the twelfth day.
In the third experiment, 10 male and 10 female control rats (average weights: males, 193 g; females, 157 g) were fed ad libitum an 8% protein diet 8 containing 8% casein, 78% starch, 10% vegetable oil, and 4% salt mixture U.S.P. XIV, to which had been added 1 kg Vitamin Diet Fortification Mixture2 per 100 pounds diet. A similar group of rats (average weights: males, 193 g; females, 157 g) was fed the same diet containing 1% lithocholic acid. The powdered diets were mixed with sufficient water to permit molding into conveniently sized balls.
Generally a 1-to 2-weeks' supply was made up and refrigerated. A ball was placed in each cage every 2 to 4 days, depending on spillage. At the end of the fourth month the surviving animals were lklled by decapitation.
In the fourth experiment, 5 control and 15 treated rats (150 to 200 g) were force fed the liquid diet of the first experiment for 1 month and then placed on the solid diet of the third experiment ad libitum. The treated animals received sodium lithocholate, 300 mg per kg per day in the liquid diet and 1% in the solid diet. After (15) .
Qualitative bile acid analysis was performed by thin layer chromatography, with the solvent systems described by Ginshirt, Koss, and Morianz (16) and Eneroth (10) , both before and after the sample was hydrolyzed in 5 N NaOH for 24 hours at 1300 C. Total bile acids were quantitated enzymatically with 3a-and 3fi-hydroxysteroid dehydrogenases. The method (to be reported in detail elsewhere) is similar to that used by Hurlock and Talalay (17) for the analysis of neutral steroids, and applied by Iwata and Yamasaki (18) to bile acids.
Isotopic studies. Sodium lithocholate-24-Y4C,' with a specific activity of 1 mc per mg, was prepared according to the method of Bergstr6m, Rottenberg, and Voltz (19) . Animals were housed in individual metabolism cages, and urine and feces were collected separately. After an intraperitoneal injection of approximately 4 X 101 dpm of sodium lithocholate-24-14C in 0.5 ml of 50% ethanol, samples of urine and of CHC13: MeOH extracts of feces and intestinal contents were counted in 1,4-bis-2-(5-phenyloxazolyl)benzene (POPOP) with a Nuclear-Chicago liquid scintillation counter with internal quench correction. Labeled bile acids in intestinal contents were chromatographed in a solvent system consisting of 50 ml butanol, 5 ml acetic acid, and 5 ml water, as described above, and radioactivity was detected with a Vanguard 885 glass plate scanner. Standard spots of glycocholic and taurolithocholic acids were located by spraying with phosphomolybdic acid (20) . The per cent of labeled compounds conjugated with taurine was calculated by cutting out and weighing the areas under the appropriate curves on the recorder strip.
Miscellaneous. Urinary taurine was measured by the method of Bergeret and Chatagner (21) , except that the Ninhydrin reaction was performed according to Rubinstein and Pryce (22) . Serum cholesterol was determined by Sackett 
Results
Morphological changes. In the acute experiments, the rats appeared to be normal, and no gross pathological changes were noted at autopsy except that one rat in the sodium lithocholate group of experiment II had a small soft calculus in the distal hepatic duct and some dilatation of the duct proximally. In the chronic experiments, the treated rats lost hair and often assumed a hunched posture. At the time of autopsy, as shown in Table I, treated female rats had not gained weight as well as controls, but treated male rats had gained normally. Liver weights in treated animals of both sexes were significantly increased over controls. In both chronic experiments, however, the most striking pathological feature was the presence of large common duct calculi in all of the treated rats (Figures 1 and 2 ). The stones were usually multiple, yellow or green, and soft and friable, but marked variations in color, size, and shape were apparent.
Livers of rats fed lithocholic acid or sodium lithocholate in both acute and chronic experiments showed microscopic changes that were essentially similar and limited to the biliary system. The por- .wall of th duc wit eqaaigcell is on th lef To investigate the metabolic changes associated with dietary prevention of stone formation, we studied several animals in each group before autopsy. Urinary taurine excretion was determined in 2 males and 2 females in each group, and the results are shown in Table IV . The urinary taurine closely reflected the total sulfur-containing amino acid content (including taurine) of the diet.
Two different males and females in each group were given intraperitoneal injections of sodium lithocholate-24-14C (4 x 108 dpm) 3 days before autopsy. Urinary bile acid-14C excretion was determined, and at autopsy the small intestinal bile acid pool was analyzed for taurine-conjugated labeled bile acids. The results are shown in Table V. Urinary excretion of labeled bile acids was similar in all groups, but females excreted more isotope in the urine on day 1 than did males (P < 0.01).
Analysis of labeled bile acids in the intestinal contents revealed significant enhancement of taurine conjugation in groups III and IV (p < 0.01).
The proportion of bile acids conjugated with taurine rose with increasing amounts of sulfur-containing amino acids in the diet and correlated well with the observed inhibition of stone formation.
Effects of diet on bile duct hyperplasia. Histological examination of the livers revealed no significant differences between the extent of bile duct proliferation in groups II, III, and IV, although the proliferation tended to be slightly more intense in group II. No correlation could be made with stone formation.
Discussion
The production of gallstones in any species by orally administered lithocholic acid has not been reported previously. Rat gallstones are extremely uncommon, presumably due to the absence of a gallbladder in this species, and the usual methods of producing gallstones experimentally in other species have not been effective in rats. The consistent production of common duct gallstones in rats by lithocholic acid, as described in this report, represents an important new toxic effect of this steroid and provides a new experimental model for the study of gallstone formation, In 1261 addition, the direct participation of one of the bile acids endogenous to man and other species in the production of biliary calculi has important implications for current concepts of the pathogenesis of cholelithiasis.
The pathogenesis of the gallstones induced in the present studies can be inferred from histological and chemical data. An early step in stone formation appears to be the precipitation of the calcium salts of free and glycine-conjugated lithocholic acid and its 6,8-hydroxy derivative in the small bile ducts. These steroids are less soluble than most common bile acids, and since calcium salts of bile acids are less soluble than sodium salts, the precipitation of these particular compounds is not surprising. In rabbits fed cholestanol, an analogous precipitation of calcium glycoallodeoxycholate also leads to stone formation (24, 25) . The composition of the stones resembles that of the naturally occurring pig gallstones, which consist mainly of lithocholic and 3,8,6a-dihydroxy-58-cholanoic acids (26) . Cellular debris, resulting from the intense desquamative and cytotoxic effects of lithocholic acid, apparently facilitates stone formation by helping to bind precipitated bile salts into microcalculi (Figures 6  to 8 ). Stones formed in this manner probably enlarge by accretion, and any stasis developing secondary to partial obstruction would undoubtedly enhance this process. Finally, microbial modification of biliary constituents may be reflected in the stone composition. Variations in the occurrence, type, or extent of biliary infection in these experiments probably accounted for the different pigments and proportions of free and conjugated bile acids formed and incorporated into these stones. Similarly, through effects on local pH and on conjugate hydrolysis, bacterial infection may have promoted further stone formation.
The prevention of lithocholic acid-induced gallstones by dietary supplements of protein or taurine is an interesting finding. Taurine is normally used preferentially for bile acid conjugation by the rat (27) , and the supply of taurine is known to be rate limiting in this reaction (28) . The low level of taurine conjugation in rats receiving the 8%o protein diet (groups I and II) suggests that this diet is deficient in the sulfur-containing amino acids (cystine and methionine) that are prerequisites for taurine formation. A deficiency of this type in the 8% protein diet is also suggested by the fact that rats gained much more weight on the 27% protein-supplemented diet (group III) than on the 8% protein diet supplemented with taurine (group IV), and it has been shown previously that taurine cannot replace the growth requirement for cystine and methionine (29) . Therefore, the ability of lithocholic acid to induce stone formation in animals on the low protein diet is probably related to the lack of sufficient sulfur-containing amino acids in this diet. Increasing the supply of actual or potential dietary taurine leads to increased availability (Table IV) and increased utilization of this amino acid for bile acid conjugation (Table V) and results in a marked decrease in stone formation. It would be of interest to know whether taurine conjugation of allodeoxycholic acid could prevent cholestanol-induced gallstones in rabbits and whether taurine administration or a high protein diet might be of benefit in some cases of human cholelithiasis.
These studies, demonstrating that lithocholic acid-induced cholelithiasis can be inhibited by enhancing bile acid conjugation with taurine but not glycine, again emphasize the importance of the specific conjugating substance in determining the physiological or pathological activity of bile acids. The exact mechanism by which taurine conjugation inhibits stone formation is not clear, but presumably the strongly polar sulfate group of taurine results in a more polar bile acid conjugate with a low pK. This conjugate, while still relatively insoluble, is considerably more soluble than glycineconjugated or free lithocholate. We have previously reported that the pyrogenic activity of lithocholic acid in man is abolished by conjugation of the steroid with taurine but not with glycine (3). Isselbacher and his co-workers have described differences between the effects of taurine-and glycine-conjugated bile salts on glucose and fat metabolism in the small intestinal mucosa (30, 31) . Other substances, such as sulfate (26) and ornithine (32), which may be found conjugated with bile acids, might also therefore be expected to affect their physiological or pathological properties. Ornithine-conjugated bile acids, with polarity characteristics intermediate between those of taurine-and glycine-conjugated bile acids, have been described by Peric-Golia and Jones (33) in the bile of certain patients with cholelithiasis. In man, lithocholic acid occurs to a significant extent as a conjugated compound more polar than either taurolithocholic or glycocholic acids (34) . The nature of this conjugating substance is unknown, but in view of the toxic effects of lithocholic acid, investigations on the composition and proporties of this conjugate will be of considerable interest.
The urinary excretion of 14C-labeled bile acids was similar in animals on different diets, with or without stones, but females in all groups consistently excreted significantly more isotope than did males. This sex difference could result from a difference in the bile acid pool sizes, from a difference in the renal tubular reabsorption of bile acids (35) , or from an inhibitory effect of estrogens on biliary bile acid excretion analogous to their effect on sulfobromophthalein excretion, which has been studied extensively by Kappas and collaborators (36, 37) . A sex difference in ability to excrete toxic bile acids into the bile might be of importance in considering the increased severity of liver disease in females, particularly during pregnancy.
In addition to gallstone formation, a second and equally important effect of lithocholic acid in these experiments was the production of marked bile duct proliferation and hyperplasia of the common duct mucosa. Liver damage induced by lithocholic acid was first observed by Holsti in 1956 (6) . He described cirrhosis of the liver in rabbits fed whole or dessicated hog bile (38) and in a series of experiments showed that this cirrhosis could be produced by a bile acid extract of hog bile (39) , by lithocholic acid (6) , and by glycolithocholic or chenodeoxycholic acids (40) . Stolk has confirmed this effect of lithocholic acid in reptiles (8) . Bile ductal and ductular cell hyperplasia in chickens fed lithocholic acid has also been reported by Hunt, Leveille, and Sauberlich (41). Eyssen, Vandeputte, and Evrard (42) found that lithocholic acid, taurolithocholic acid, and 3-ketocholanic acids could all produce these changes in chickens, but that chenodeoxycholic acid could not. Similar changes have been observed in guinea pigs, hamsters, and monkeys (7, 9) and to a lesser extent in rats and mice (7, 42) . The apparent resistance of rats to these effects of lithocholic acid is of interest and could have been related in part to the presence of enzyme systems in rat and mouse livers capable of catalyzing the extensive hydroxylation of lithocholic acid at the 6a, 6,8, and 7a positions (43) and thus presumably inactivating it. Such changes have been shown to decrease the hemolytic and cytotoxic activity of lithocholic acid (3) (4) (5) . Therefore, large doses of lithocholic acid were used in these experiments, and extensive bile duct proliferation was noted in all animals, both on the low (8%) and normal (27%o) protein diets.
The pathological changes produced by lithocholic acid in rats were slightly different from those seen in chickens and rabbits. Marked bile duct proliferation was present, but sheet-like or finger-like areas of proliferating ductular cells, the "ductular cell reaction" (41) seen in other species, were not as prominent. Instead, large numbers of infiltrating eosinophilic leukocytes were seen in portal areas with damaged bile ducts and in the walls of the large hepatic and common bile ducts. These cells have not been described as part of the response to lithocholic acid in other species, and their significance is entirely speculative.
The ductular reaction apparently occurred without significant mechanical obstruction. It was seen in acute experiments without demonstrable extrahepatic stone formation [increased incorporation of tritiated thymidine occurs within 24 hours (44)] ; there was extensive epithelial proliferation in the common duct down to the point where it enters the duodenum (presumably below any obstruction); and electron micrographs failed to show canalicular dilatation. The relation between biliary tract obstruction and cellular proliferation was investigated by Jacoby in the guinea pig (45) . Ligation of the common duct produced an increase in mitotic activity of all cells in the gallbladder, starting with the epithelial cells. Ligation of the cystic duct and distention of the gallbladder with paraffin did not result in increased mitotic activity, indicating that increased pressure was not the sole stimulus for proliferation. Fry and Staffeldt (46) have shown that deoxycholate-fed mice have a greatly increased cell turnover, in both the gallbladder and the small intestine, as determined by the uptake of tritiated thymidine, but ductal proliferation was not observed. These studies are consistent with the idea, suggested by Hunt, Leveille, and Sauberlich (7), that excretion of lithocholic acid or a metabolite may be a specific 1263 stimulus to ductal or ductular cell hyperplasia. The similarity between the early and late lesions in our rats, together with the absence of cirrhosis in the chronic experiments, is consistent with the hypothesis that the lesions are directly related to the continuing stimulus of some such agent. Furthermore, when lithocholic acid is removed from the diets of rabbits (38) and chickens (41) , the lesions regress. Alternatively, the proliferation may be simply a nonspecific response to the cytotoxic effects of lithocholic acid. Unpublished studies indicate that cellular proliferation induced by lithocholic acid can be largely prevented by the simultaneous feeding of cholic acid and cholesterol, even in the presence of significant stone formation. In contrast, as reported here, taurine supplementation suppressed stone formation but not ductal proliferation, suggesting that ductal hyperplasia and gallstone formation occur by different mechanisms.
The liver and biliary tract changes seen in rats after lithocholic acid administration were remarkably similar to those produced by vitamin A deficiency (47, 48) . Hamre observed extensive bile duct proliferation in several of his vitamin A deficient rats (48) , and in a high percentage of animals he found epithelial cells sloughing off in the small bile ducts and accumulating behind the ampulla to form large calculi. He also noted eosinophilic infiltration in the wall of the common duct around the stones. The similarity between these findings and those in lithocholic acid-fed rats is striking; however, specific signs of vitamin A deficiency were not observed in our rats, and further experiments have shown that vitamin A administration does not inhibit lithocholic acid-induced stone formation despite the presence of greatly increased liver and serum levels of vitamin A.
Lithocholic acid-induced cholelithiasis and bile duct proliferation in rats have relevance to human disease because of the important role of lithocholic acid in human bile acid metabolism. Lithocholic acid is formed in the intestine as a result of bacterial dehydroxylation of chenodeoxycholic acid at carbon 7. The transformation is an efficient one, in view of the paucity of C7 hydroxylated bile acids in feces, and a reasonable estimate for the daily production of lithocholic acid in humans would be 100 to 400 mg. In some individuals, lithocholic acid may undergo further metabolic transformations, mainly to the 3/3-hydroxy isomer, isolithocholic acid (34) , and it is now generally agreed that these two monohydroxycholanic acids form a large (25 to 50%o) fraction of the total fecal bile acids (49) (50) (51) . The extent of lithocholic acid metabolism, which is highly variable, may well be of great importance in determining the amount of lithocholic acid absorbed from the intestine; its major metabolite, isolithocholic acid, apparently is not well absorbed, and exceedingly small amounts are present in bile (34) . Lithocholic acid is absorbed, however, and has been tentatively described in human serum by Mihaesco and Fauvert (52) (3) .] Lithocholic acid has also been described in bile in similar proportions by Hauton, Greusard, Perrot, and Sarles (57) and by Kuksis (51) , but the problems of extraction, hydrolysis, and recovery of lithocholic acid are such (34, 54) that these figures may be regarded as minimal. Rosenfeld has isolated 91 mg of lithocholic acid as the methyl ester from 41 ml of human gallbladder bile (58), a figure close to 5%o of the total estimated pool size. More meaningful data, with respect to gallstone formation, would relate to the concentration of lithocholic acid relative to its solubility in bile; unfortunately these are not available, but lithocholic acid and its taurine and glycine conjugates are all highly insoluble in aqueous media, even at neutral pH. Lithocholic acid has been reported among free bile acids isolated from human gallstones (59, 60) , and recently it has been shown to produce cholestasis after its intravenous infusion in rats (61) , an activity of importance with respect to both bile duct proliferation and gallstone formation. The presence of this highly insoluble and inflammatory substance in human bile and gallstones strongly suggests that serious consideration be given to its possible role in human as well as animal cholelithiasis.
Finally, lithocholic acid must be regarded as an endogenous compound potentially capable of producing bile duct proliferation in human liver disease. It has the capacity to produce this lesion in all species studied to date, from reptiles to mammals, and its daily production in humans is of the same order of magnitude as that required to produce bile duct proliferation in rabbits and chickens. Particular consideration should be given to its possible role in diseases such as ulcerative colitis, in which protein deficiency frequently coexists with a loss of mucosal integrity and large amounts of lithocholic acid might be absorbed and presented to an unusually susceptible liver.
Summary
The oral administration of 1%o lithocholic acid in a low protein diet consistently produced bile duct proliferation and common duct gallstones in rats. The proliferation was fully developed after 5 days of lithocholic acid administration, did not increase with long term feeding, and was independent of gallstone formation. The gallstones resulted from precipitation of the calcium salts of free and glycine-conjugated lithocholic acid and its 6,8-hydroxy derivative. The stones could be prevented by increasing the dietary content of sulfur-containing amino acids and thus enhancing bile acid conjugation with taurine. The consistent production of choledocholithiasis in rats, as described in these studies, provides a new experimental method for studying gallstone formation.
